Regulatory note: 5-Amino-1MQ is not FDA-approved for any use and has not been studied in completed human clinical trials
So the goal of the B12 component is correction and prevention: keeping levels from dropping during treatment, which can in turn help offset the fatigue, brain fog, and irritability that may otherwise show up around weeks 4 to 8 of GLP-1 treatment
Specialist Sales liability is limited
patient in intramuscular arm provide appointments for injections Visit 2 (week 8) Anamnesis: record lifestyle habits and use of alcohol Symptoms: if pathological at the first visit, record paresthesia, asthenia, loss or reduction of appetite, sadness or change in level of happiness, and concomitant pharmacological treatment Physical examination: if pathological at the first visit examine for Hunters glositis, positional and vibrational sensitivity Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Questionnaires: EuroQoL-5D Assessment of adverse effects Therapeutic plan: patient in oral arm provision of medication
Can I have Vitamin B12 Injections
